Unusual 11 Mid-Day Movers 8/5: (LNTH) (PTCT) (WLDN) Higher; (CPSI) (HDP) (IMI) Lower

August 5, 2016 12:54 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Lantheus Holdings (Nasdaq: LNTH) 53.5% HIGHER; reported Q2 EPS of $0.24, $0.18 better than the analyst estimate of $0.06. Revenue for the quarter came in at $78 million versus the consensus estimate of $72.66 million. Lantheus Holdings sees FY2016 revenue of $291 - $295 million, versus the consensus of $290.8 million.

Computer Programs & Systems (Nasdaq: CPSI) 30.2% LOWER; reported Q2 EPS of $0.48, $0.31 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $68.4 million versus the consensus estimate of $74.35 million.

PTC Therapeutics (Nasdaq: PTCT) 29.5% HIGHER; reported Q2 EPS of ($1.14), $0.13 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $15.6 million versus the consensus estimate of $14.68 million.

Hortonworks (Nasdaq: HDP) 27.4% LOWER; reported Q2 EPS of ($0.72), $0.02 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $45.26 million. Hortonworks sees Q3 2016 revenue of $45 million, versus the consensus of $49.3 million. Hortonworks sees FY2016 revenue of $177 million, versus the consensus of $191.4 million.

Willdan Group (Nasdaq: WLDN) 26.1% HIGHER; reported Q2 EPS of $0.37, $0.14 better than the analyst estimate of $0.23. Revenue for the quarter came in at $58.9 million versus the consensus estimate of $49.55 million. Willdan Group sees FY2016 EPS of $0.84-$0.91, versus the consensus of $0.74. Willdan Group sees FY2016 revenue of $175-190 million, versus the consensus of $177.07 million.

Freshpet (Nasdaq: FRPT) 25.5% HIGHER; reported Q2 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $33 million versus the consensus estimate of $32.92 million.

Intermolecular (Nasdaq: IMI) 25.2% LOWER; reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.2 million. Intermolecular sees Q3 2016 EPS of ($0.12)-($0.10), versus the consensus of ($0.03). Intermolecular sees Q3 2016 revenue of $9.5-10.0 million, versus the consensus of $14.2 million.

Ocular Therapeutix (Nasdaq: OCUL) 21.9% HIGHER; adding to yesterday's 34 percent gain after provding an update on the status of its New Drug Application (NDA) for DEXTENZA (dexamethasone insert) 0.4 mg, for intracanalicular use in the treatment of ocular pain occurring after ophthalmic surgery.

Inuvo, Inc. (NYSE: INUV) 20.0% LOWER; reported Q2 results. Net revenues for the three months ended June 30, 2016, were $15.6 million compared to $16.7 million for the three months ended June 30, 2015. For the quarter ended June 30, 2016, GAAP net loss was $575 thousand or $0.02 net loss per share compared to $445 thousand net income, or $0.02 net income per diluted share, for the quarter ended June 30, 2015.

Kratos Defense (Nasdaq: KTOS) 18.9% HIGHER; reported Q2 EPS of ($0.17), $0.10 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $168.2 million versus the consensus estimate of $158.93 million. Kratos Defense sees FY2016 EPS of $659.00, versus prior guidance of $649.00 and the consensus of $648.70.

Sierra Wireless (Nasdaq: SWIR) 18.2% LOWER; reported Q2 EPS of $0.20, $0.08 better than the analyst estimate of $0.12. Revenue for the quarter came in at $156.2 million versus the consensus estimate of $154.39 million. The company said: For the third quarter of 2016, we expect revenue to be in the range of $145 million to $155 million and non-GAAP earnings per share to be in the range of $0.06 to $0.13. In the fourth quarter of 2016, we expect to see sequential and year-over-year growth, although not to the levels previously anticipated. Given this softer short term outlook, we now expect full year 2016 revenue and non-GAAP EPS to be below the low end of our previously stated annual guidance range of $630 million to $670 million in revenue and non-GAAP EPS of $0.60 to $0.90.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers, Earnings

Add Your Comment